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xv
IDENTIFICATION OF ABRB AND SPO0A BINDING SITES ON                                 
B. SUBTILIS YVFI  PROMOTER 
SUMMARY 
The model organism for the gram-positive bacterium, B.subtilis, can produce more 
than 20 antibiotics which are predominantly peptides. Bacilysin is a dipeptide 
containing L-alanine at its N-terminal and the unusual amino acid L-anticapsine at its 
C terminal. It is produced by certain strains of B.subtilis against some bacteria and 
fungi and interferes with the synthesis of microbial cell walls. The unusual amino 
acid L-anticapsin moiety of bacilysin is generated through the action of a prephenate 
dehydratase and an aminotransferase, products of ywfBG genes, respectively. The 
biosynthesis of the dipeptide bacilysin depends on the ywfBCDEF gene cluster which 
was renamed as bacABCDE. Furthermore, disruption of these genes by plasmid 
integration was shown to cause loss of the ability to produce bacilysin, and also a 
lack of bacilysin synthetase activity in the crude extract. While bacABC genes carry 
the anticapsin synthesis function, the bacD and bacE genes encode for the function 
of amino acid ligation and self-protection to bacilysin, respectively.  
Distruption of phrC, comA and oppA by Tn10 transposon mutagenesis and 
introduction of comQ::cat mutation resulted in the elimination of bacilysin 
biosynthesis, demonstrating that bacilysin biosynthesis is under the feedback 
regulation by the components of global quorum sensing control system. Also, it was 
shown that bacilysin production is regulated on different levels negatively by GTP 
via the transcriptional regulator CodY and AbrB.  
 
During the transition-state from vegetative to stationary phase, a wide variety of two 
component signal transduction systems and global regulators of B. subtilis are 
activated in response to the environmental signals. These regulators have been 
termed transition-state regulators and AbrB, Spo0A, ScoC and Cody are some 
important members of this regulatory protein class. It is undoubtedly known that 
transition state regulator proteins, AbrB and Spo0A have crucial roles in the 
biosynthesis of antibiotics and toxins in Bacillus species. When it comes to the 
bacilysin, it has been proved that bacilysin is also under the regulation of abrB and 
spo0A genes. Insertional mutation in abrB gene resulted in an increase in bacilysin 
production, indicating that bacilysin synthesis is under the negative control of abrB 
gene and moreover it was demonstrated that spo0A blockage resulted in a crucial 
decrease in bacilysin synthesis. 
 
Very recently, through Tn10 mutagenesis studies that were performed to reveal 
related genes with bacilysin biosynthesis in Bacillus subtilis PY79 strain, yvfI gene 
which is similar to transcriptional regulator (GntR family) was found responsible in 
bacilysin production. On the other hand, since yvfI gene is essential for the bacilysin 
biosynthesis, any gene involved in the regulation of yvfI were considered as 
candidates in the regulation of bacilysin production indirectly. Subject to the 
  
xvi
foregoing provisions, in this study, yvfI gene promoter by DBTBS database was 
examined in order to find putative cis-elements in the promoter region of the B. 
subtilis yvfI gene for candidate regulatory proteins and found putative binding sites 
for AbrB and Spo0A regulatory proteins. AbrB and Spo0A proteins were tested for 
their abilities to bind the yvfI promoter DNA in electromobility shift experiment. 
Furthermore, DNase I footprinting of the yvfI promoter was applied in order to 
discover the exact regions occupied by AbrB and Spo0A trans-acting regulatory 
factors. According to the electropherograms obtained from the capillary-based 
instrument and then aligned using GeneMapper software, binding sites for each 
regulatory protein on yvfI promoter were determined. Data obtained in this study 
suggested that  AbrB and Spo0A regulatory proteins have roles in the bacilysin 
biosynthesis by regulating yvfI gene expression on transcriptional level. 
 
 
 
 
Key words: B. subtilis, bacilysin, yvfI gene, AbrB regulator protein, Spo0A regulator 
protein, Electromobility shift assay, DNase I footprinting. 
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ABRB VE SPO0A TRANSKRĐPSĐYON FAKTÖRLERĐNĐN B. SUBTILIS 
YVFI  PROMOTORUNDAKĐ BAĞLANMA BÖLGELERĐNĐN BULUNMASI 
ÖZET 
 
Gram-pozitif organizmalar için model organizma olarak kabul edilen B.subtilis, 
ağırlıklı olarak peptid olan 20’den fazla antibiyotik üretebilmektedir. Basilisin, N 
ucunda L-alanine ve C ucunda doğal olmayan bir aminoasit olan L-anticapsine 
bulunduran  iki aminoasitten oluşan bir dipeptidtir. B. Subtilis’un bazı şuşları 
tarafından üretilen basilisin, bazı bakteri ve mayalara karşı kullanılmaktadır ve 
mikrobiyal hücre duvarı sentezini engellemektedir. Basilisinin doğal olmayan L-
antikapsin amino asidinin, sırasıyla ywfBG genlerinin ürünleri olan prefenat 
dehidrataz ve aminotransferaz enzimleri aracılığıyla üretildiği düşünülmektedir.  
Basilisinin biyosentezi, daha sonra bacABCDE olarak adlandırılan ywfBCDEF gen 
kümesi tarafından gerçekleşmektedir. Söz konusu gen kümesinin, plazmid 
entegrasyonu ile bozulması sonucu basilisin üretimi durmuş, ayrıca hücre özütünde 
basilisin sentetaz aktivitesi kaybolmuştur. Daha sonra yapılan çalışmalarda, bacABC 
genlerinin antikapsin üretiminden sorumlu olduğu, bacD ve bacE genlerinin ise 
sırasıyla amino asid ligasyonu ve basilisine karşı korunma fonksiyonlarını 
gerçekleştirdiği kanıtlanmıştır.  
 
phrC, comA and oppA genlerinin Tn10 mutagenez yolu ile bozulması veya 
comQ::cat mutasyonunun oluşturulması, basilisin biyosentezinin durmasıyla 
sonuçlanmıştır. Bu çalışmalar basilisin biyosentezinin global quorum sensing kontrol 
sistemi tarafından regule edildiğini göstermektedir. Ayrıca, basilisin üretiminin AbrB 
ve GTP ile negatif olarak düzenlediği gösterilmiştir. 
 
B. subtilis, vegetatif formdan durgun faza geçerken, çevresel sinyallere tepki olarak 
iki bileşenli sinyal iletim sitemlerinin birçoğunu ve çeşitli global düzenleyicilerini 
aktif hale getirir. Bu düzenleyiciler, geçiş (dönüşüm)- düzenleyicileri olarak 
isimlendirilir. AbrB, Spo0A, ScoC ve Cody proteinleri bu düzenleyici protein 
sınıfının en önemli üyelerinden birkaçıdır. AbrB ve Spo0A geçiş-düzenleyici 
proteinlerinin Basillus türlerinde antibiyotik ve toksin biyosentezinde önemli 
görevleri olduğu kesin olarak bilinmektedir.  Sözkonusu basilisine geldiğimizde, 
basilisinin de abrB ve spo0A genleri tarafından regule edildiği gösterilmiştir. abrB 
geninde oluşturulan mutasyonlar sonucu basilisin üretiminde meydana gelen artış, 
basilisin sentezinin abrB geninin negative kontrolü altında olduğunu göstermiştir. 
Aynı çalışmada, spo0A geni bloke edildiğinde basilisin üreteminde büyük bir düşüş 
olduğu gösterilmiştir.  
 
Bacillus subtilis PY79 şuşunda basilisin üretimiyle ilgili genleri açığa çıkarmak için 
son zamanlarda yapılan Tn10 mutagenesis çalışmaları, transkripsiyonel 
düzenleyiciye benzeyen yvfI geninin (GntR ailesi)  basilisin biyosenteziyle ilgisi 
olduğunu kanıtlamıştır. Bununla birlikte, yvfI geninin basilisin üretiminden sorumlu 
  
xviii 
olması nedeniyle, yvfI geninin düzenlenmesinde görev alan herhangi bir gen dolaylı 
olarak basilin üretiminden de sorumludur. Yukardaki çıkarımdan hareketle, DBTBS 
veritabanı (Sierro et al, 2008) kullanılarak B. subtilis yvfI geninin promoter dizisi, 
aday düzenleyici proteinlerin bağlanabileceği cis-elementlerinin bulunması için 
incelendi, ve AbrB ile Spo0A düzenleyici proteinleri için olası bağlanma bölgeleri 
bulundu. Elektromobility shift deneyi ile AbrB ve Spo0A proteinlerinin yvfI 
promoter DNA dizisine bağlandıkları bulunduktan sonra, söz konusu düzenleyici 
proteinlerin (trans-acting protenlerin) yvfI promoter dizisinde bağlandıkları bölgeleri 
açığa çıkarmak için DNase I footprinting deneyi gerçekleştirildi. Kapiler tabanlı 
araçtan elde edilen ve sonrasında GeneMapper programı kullanılarak düzenlenen 
electrophoregramlar incelendi ve her bir düzenleyici protein için yvfI promoter dizisi 
üzerinde bir bağlanma bölgesi bulundu. Elde edilen sonuçlar, AbrB ve Spo0A 
düzenleyici proteinlerinin, basilisin üretimini yvfI geninin ekspresyonunu 
transkripsiyon düzeyinde değiştirerek düzenlediklerini açığa çıkarmıştır. 
 
 
 
Anahtar Sözcükler : B. subtilis, basilisin, yvfI geni, AbrB düzenleyici protein, 
Spo0A düzenleyici protein, Elektromobility shift, DNase I footprinting. 
 
 
 
 
 
 
1
1.  INTRODUCTION 
1.1. Bacillus subtilis 
Bacillus subtilis is an endospore-forming rhizobacterium that has always been a 
popular model system for genetic and biochemical investigations due to the 
identification and mapping of most of the genetic loci in B.subtilis (Stein, 2005; 
Harwood et al., 1990).   
Ferdinand Cohn identified and named the bacterium Bacillus subtilis in 1872. The 
organism was placed in the family Bacillaceae. As a member of the genus Bacillus, 
B. subtilis is characterized as rod shaped, gram positive, aeobic or facultative bacteria 
and has the ability of forming a protective endospore, a highly refractile resting 
structure formed within the bacterial cell and helps the bacterium survive in extreme 
environmental conditions (Sonenshein et al.,1993 and Harwood et al., 1990). In 
1961, by the mean of developed fluorescent antibodies against the different proteins 
produced in vegetative and spore forming  B. subtilis, it was observed that this 
species was mostly in its vegetative form (Norris  and Wolf).  
Due to the increase in sequence information in DNA technology, it was revealed that 
B. subtilis 168 strain has no genes encoding the virulance factor, which is also 
compatible with the knowledge that bacterium is not pathogen (Kunst et al., 1997) 
Contrary to the knowledge that B. subtilis is an obligate aerobe, recent studies have 
revealed putative nitrate reductase genes, which explains the source of nitrate 
molecules used as an electron acceptor molecule rather than oxygen when bacterium 
faces to  anaerobic conditions (Kunst et al., 1997). In an attempt to identify the 
fermentation pathway in B. subtilis under anaerobic conditions, fermentation end 
products were analyzed by using in vivo nuclear magnetic resonance scans of whole 
cultures and demonstrated anaerobic growth of B. subtilis in the presence of nitrate 
(Nakano et al., 1997).  
 
 
2
1.2. Bacillus subtilis Genome 
Bacillus subtilis is the most studied gram-positive bacteria in genome level. The 
complete sequencing of the Bacillus subtilis 168 genome has been published, which 
was done by a European and a Japanese sequencing consortium and a Korean 
laboratory. Its genome  was proposed to consist of 4,214,810 corresponding to  4100 
protein coding genes. G+C content of the B.subtilis genome is about %43 and more 
than a quarter of the genome is predicted to encode several gene families. Moreover, 
a remarkable proportion of its genome was found to be responsible for the utilization 
of different carbon sources, including many plant-derived molecules and synthesis of 
secondary metabolites such as antibiotics which are especially related with 
Streptomyces species. More than ten prophages or prophage remnants in genome 
demonstrated the crucial role of bacteriophage infection on the evolutinary of 
horizontal gene transfer (Kunst et al., 1997, Ghim et al., 1998). 271 of 4200 genes 
are considered as essential genes which are required for sustaining a living cell and 
roughly half of them are directly involved in DNA, RNA and protein metabolism 
(Kobayashia et. al., 2003). 
Revealing of B. subtilis 168 strain sequence showed that about % 4 of its genome, 
corresponding to nearly 350 kb, is devoted to produce secondary metabolites and 
antimicrobial compounds which serve as effective inhibitors like antibiotics against 
the fungi, bacteria and plants. They are proposed to help the bacterium to compete 
for the nutrients in extreme environmental conditions (Stein, 2005; Kunst et al., 
1997). 
1.3. B. subtilis Antibiotics 
Antibiotics produced by the bacteria of the genus Bacillus can be divided in two 
groups in general; first group includes small and cyclic lipopeptides whose structures 
involves uncommon amino acids such as ornithine or D-amino acids and sometimes 
beta amino acids (Lebbadi et al. 1994; Munimbazi and Bullerman 1998). Second 
group contains hydrophilic antibiotics such as the dipeptide bacilysin and 
phosphonooligopeptide rhizocticin (Walker and Abraham 1970; Kugler et al. 1990). 
Through the genus Bacillus, B. subtilis is considered as the major source for 
antibiotic production and produces more than twenty antibiotics with unusual amino 
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acids (Asaka and Shoda 1996). Post-translational modification, proteolytic  
processing in ribosomal way and non-ribosomal synthesis by the large megaenzymes 
called non-ribosomal peptide synthetases (NRPSs) stand for the main reasons of 
unusual aminoacids in B.subtilis antibiotics (Moszer,1998 and Stein et al., 2005). 
Recently, B. subtilis, among gram-positive members of the aerobic, spore-forming 
genus Bacillus is used as a biocontrol agent thanks to its great abundance of 
antibiotics showing the broad spectrum activity (Stein, 2005; Moszer, 1998; Expert 
and Digat, 1995). Most of the B. subtilis antibiotics are peptides and produced by 
ribosomal or non-ribosomal way. Spectrum action, resistance to peptidase and 
protease hydrolysis are the parameters which stipulate their effectiveness (Souto et 
al., 2004; Stein, 2005). 
In general, B. subtilis antibiotics are resistant to high temperature, a wide range of pH 
and many hydrolytic enzymes. Recently, it has been proved that most of the in vivo 
B. subtilis antibiotics are stable and do not show any significant difference in activity 
when they were treated with high temperature (121oC for 20 min), a broad range of 
pH (from 4 to 10) and hydrolytic enzymes such as trypsin, proteinase K, and lipase A 
(Souto et al., 2004).  
Some antibiotics of B. subtilis display completely dinstinct roles in addition to their 
anti-microbial mission, especially have roles on the morphology and physiology of 
B. subtilis. For instance, non-ribosomal produced antibiotics are not only involved in 
antimicrobial action, but also have roles on colony formation and biofilm. 
Furthermore, lantibiotics act as effective factors in programmed cell death and 
quarum sensing mechanism in B. subtilis (Stein, 2005). 
1.3.1. Ribosomal Synthesis: Lantibiotics 
Lantibiotics are a group of peptide bacteriocins including unusual 3-
methyllanthionine and thioether amino acids lanthionine due to post-translational 
modifications; dehydration of serine and threonine residues and then  addition of 
cysteine thiol groups. The name lantibiotics stands for lanthionine-containing 
antibiotic peptides (Chatterjee et al., 2005). They are synthesized as procursors 
molecules by ribosomal pathway and after the activation by proteolysis, are exported 
out of the cell (Figure 1.1). The genes responsible in biosynthesis and pathway of 
lantibiotics are found in gene clusters (Guder et al, 2000). 
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According to the structural properties, lantibiotics are seperated in two groups: Type 
A lantibiotics, consisting of 21–38 amino acid residues, exhibit a more linear 
secondary structure and kill gram-positive target cells by forming voltage-dependent 
pores into the cytoplasmic membrane. On the contrary, type B lantibiotics have a 
more globular structure and have comparatively small charges (Breukink et. al, 1999; 
Mannanov et al., 2001). 
 
Fig. 1.1: A few Bacillus subtilis lantibiotics, lantibiotic-like peptides and  specifying  
                gene clusters (Guder et al, 2000). 
1.3.2. Non-ribosomal Biosynthesized Peptides 
Some of the peptide antibiotics of B. subtilis are synthesized through the large 
multienzymes called the non-ribosomal peptide synthetases (NRPSs). Selection and 
condensation af the amino acids in peptide are performed by the three catalytic 
domains of the NRPSs according to the multiple-carrier thiotemplate mechanism. 
Each elongation cycle in non-ribosomal peptide biosynthesis needs the cooperation 
of three core domains. Three catalytic domains of the NRPSs; adenylation domain,  
peptidyl carrier domain and condensation domain selects the amino acid, tranfers the 
adenylated amino acid substrate to its prosthetic group and finally catalyses the 
formation of a new peptide bond respectively. The unit of these three core domains 
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which catalyse all the necessary reactions in peptide biosynthesis form a structure 
called module. The arrangement of the modules constitutes the NRPSs (Walker et al., 
1970; Lambalot et al., 1996; Stein et al., 2005).  
1.4. Roles of spo0A and abrB in Antibiotic Biosynthesis 
Under unfavorable conditions like nutrient deprivation and high cell density, B. 
subtilis undergoes a cellular differentiation process called sporulation, leading to the 
formation of a dormant spore (Phillips and  Strauch, 2002). During this transition 
state from vegetative to sporulation phase, a wide variety of two component signal 
transduction systems of B. subtilis are activated in response to the environmental 
signals. Also, small peptide pheromones are excreted and imported by B. subtilis in 
order to sense the environmental situation (Fabret et al., 1999: Stephenson and Hoch 
2002). According to the environmental conditions and signals, various antibiotics 
and antimicrobial factors are excreted out of the cell in order to outcompete other 
microbial species. Production of and resistance to antibiotics are regulated through 
spo0-abrB control system (Figure 1.2). Signals, indicating the hard conditions such 
as high cell density or nutritional stress, pump into cell and promote the Spo0 
phosphorelay, eventually causing the accumulation of Spo0A phosphate (Spo0A-P), 
which activates sporulation gene transcription. Phosphorylated Spo0A (Spo0A-P) 
has a higher DNA binding affinity to the abrB promoter and thus represses the 
transcription of the transition state regulatory gene, abrB. The concentration of the 
AbrB drops below its critical threshold value, and thus AbrB-dependant repressive 
effects over the production of different antibiotics and other stationary phase related 
products are lifted (Burbulys et al, 1991; Ireton et al, 1993; Strauch et al, 1990). 
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Fig. 1.2: The Phosphorelay. The main interactions that occur within and associated   
       with the phosphorelay are illustrated. Arrows indicate activation, and  
                 barred lines indicate repression. Phosphorylated forms of proteins are 
                 indicated by ~P (Phillips and  Strauch, 2002). 
AbrB protein regulates more than 40 genes directly by binding their promoters or 
regulatory regions (Strauch 1993, Strauch 1995a). Additionally, many regulator 
proteins are also under the control of AbrB such as SinR and Abh regulatory 
proteins, since it is also a regulator molecule of other regulator proteins (Fawcett et 
al, 2000; Strauch et al, 2007).  The genes which are controlled directly or indirectly 
by AbrB take part in a wide variety of metabolic processes such as antibiotic 
synthesis, nitrogen utilization, amino acid metabolism, development of competence 
and sporulation (Hahn et al, 1995; Robertson et al, 1989).  
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It is known that AbrB protein regulate several genes which are expressed in the 
transition state from exponential growth to stationary phase by binding directly on 
their promoter regions  (Robertson et al, 1989; Strauch et al, 1989). Dimerization and 
multimerization of the AbrB protein are crucial steps for its binding to target DNA. 
As a result of dimerization of two identical monomeric subunits, a saddle-like cleft is 
formed into which target DNA fits and AbrB protein contact one face of the DNA 
helix (Xu and Strauch, 1996b; Strauch, 1995a; Vaughn et al, 2000).  
AbrB changes the gene expression in three ways after binding on regulatory regions 
of DNA. AbrB can be a repressor (negative regulator) for some genes, and these 
genes are expressed constantly in abrB mutants since repression of AbrB over these 
genes is eliminated. Secondly, and most commonly, AbrB can act as inhibitor for 
some genes. In this manner, AbrB protein is a inhibitory factor which act on 
redundant regulatory network to prevent the control of other regulators over the 
genes that must be inactive. Thirdly, and finally, AbrB can be an activator for some 
genes. In fact, up to now, there has not been reported any case of RNA polymerase 
activation by AbrB. It is thought that AbrB protein is a negative regulator of other 
negative regulators; so that eliminate the negative control by binding the DNA region 
which is also available for other negative regulators (Strauch, 1993; Strauch and 
Hoch, 1993; Strauch, 1995b). 
It is undoubtedly known that transition state regulator protein AbrB and sporulation 
initiation gene Spo0A have crucial roles in the biosynthesis of antibiotics and toxins 
in Bacillus species (Figure 1.3). So far, much more is known about the antimicrobial 
encoding genes and operons which are regulated by Abrb and Spo0A. For instance, it 
has been found that AbrB negatively regulates cyclic bacteriocin subtilosin through 
the antilisterial bacteriocin operon (alb) and sbo gene, which encodes the precursor 
of subtilosin (Zheng et al, 1999). Also, tasA operon whose product is an 
antimicrobial protein called TasA is under the control of transition state regulatory 
genes spo0A and abrB positively and negatively, respectively (Stover and Driks, 
1999). In addition to these findings, recently, it was proven that transcription of бW 
regulon in B. subtilis, which activates the genes responsible in the production of 
antimicrobials and detoxification functions is subject to abrB negative control (Qian 
et al, 2002).  Moreover, mutations in spo0A gene makes the B. subtilis unable to 
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produce some certain antibiotics and sensitive to some antibiotics produced by wild-
type B. subtilis (Zuber et al, 1987).  
 
Fig. 1.3: Regulatory pathways of antibiotic biosynthesis in B. subtilis. Positive and     
             negative regulation of gene expression is indicated by arrows and T-bars   
              respectively. For clarity, the repression of AbrB on sbo-alb and tasA was  
                 omitted (Stein, 2005). 
1.5. Bacilysin 
Bacilysin [L-alanyl-(2.3-epoxycyclohexanone-4)-L-alanine] is one of the simplest 
and smallest peptide antibiotics synthesized and excreted by some bacteria of the 
genus Bacillus such as B . amyloliquefaciens, B. licheniformis and B. pumilus and B. 
subtilis 168 strain (Figure 1.4). Bacilysin is formed during the second phase of 
slower growth, and there is little production during the stationary phase (Loeffler et 
al., 1986; Walker et al. 1970; Stein et al. 2005). It is a dipeptide that consist of an L-
alanine residue at the N terminus and a non proteinogenic amino acid, L-anticapsin, 
at the C terminus (Chatterjee et al. 2005).  
Antibiotic activity of bacilysin depends on the L-anticapsin moiety, which is released 
by peptidases after uptaken of bacilysin into the cell by a peptide permease system 
(Kenig et al. 1976; Chmara et al. 1982; Perry and Abraham 1979). L-anticapsin, 
then, blocks the glucosamine synthetase, thereby, bacterial peptidoglycan or fungal 
mannoprotein synthesis leading cell to protoplasting and cell lysis (Kenig et al. 1976; 
Chmara et al. 1982; Chmara 1985; Milewski 1993). 
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Fig. 1.4: Structural formula of bacilsin (Mannanov et al., 2001). 
1.5.1. Genetic Mechanism of Bacilysin Biosynthesis  
The biosynthesis of the dipeptide bacilysin depends on the ywfBCDEF gene cluster 
and renamed bacABCDE (Figure 1.5). It has been  proved that the disruption of these 
genes by plasmid integration causes the loss of the ability to produce bacilysin, and 
also a lack of bacilysin synthetase activity in the crude extract (Inaoka et al., 2003). 
The unusual amino acid anticapsin moiety of bacilysin is probably generated through 
the action of a prephenate dehydratase and an aminotransferase, products of ywfBG 
genes, respectively (Roscoe and Abraham 1966; Hilton et al., 1988). According to 
the similarity features of the bacABC genes, mentioned proteins are most similar to 
following proteins; BacA to prephenate dehydratases, BacB to isomerase/guanylyl 
transferases and BacC to different oxidoreductases. Therefore, the products of 
bacABC genes are good candidates for catalysing the conversion of  prephenate to 
anticapsin (Inaoka et al., 2003; Roscoe and Abraham 1966; Hilton et al. 1988). So as 
to investigate the involved genes in anticapsin production, the candidate bacABC 
genes were transformed into a B. subtilis ∆ (ywfA-bacABCDE) deletion mutant and 
resulted in the accumulation of the anticapsin. Furthermore, individually disruption 
of the each chromosomal genes  bacA, bacB or bacC, in three different mutants 
(bacA::catR-bacBCD, bacA-∆bacB::catR-bacCD and bacAB-∆bacC::catR-bacD), 
blocked anticapsin synthesis in each mutant, strongly suggesting the active roles of 
bacABC genes in anticapsin production (Steinborn, et al. 2005).  
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Fig. 1.5: Organization of the bacilysin gene cluster bacABCDE relative to open      
                 reading frames ywfABCDEFG of Bacillus subtilis 168. Restriction sites   
       used are indicated at the base pair counted from the upstream PstI    
                   site. The DNA comprises the sequence from 3875148–3867678 bp of the   
               SubtiList database R16.1 (Kunst et al. 1997). Proposed terminator (T0)   
       elements are indicated according the SubtiList database. Sigma A   
       promoter (P) elements -35 (TTGACA) and -10 (TAAAATt) were  
                  tentatively detected 56 bp and 33 bp upstream of the ATG codon of the  
                    bacA gene (Steinborn, et al. 2005). 
On the other hand, bacilysin synthesis is proposed not to depend on the multiple 
carrier thiotemplate model requiring non-ribosomal peptide synthetases (Yazgan, et 
al., 2001), the peptide bound between the L-alanine and L-anticapsin must be 
proceeded in a non-ribosomal mode, most likely by an amino acid ligase referred as 
bacilysin synthetase (Sakajoh et al. 1987). In addition to this, since BacD protein was 
most similar to D-alanine - D-alanine ligase, the deduced protein was a good 
candidate to catalyse the proposed peptide bound ligation between the L-alanine and 
L-anticapsin (Inaoka et al., 2003). After complementation of bacD-deficient mutant 
(bacABC-∆bacD::catR) by the plasmid with bacD gene, bacilysin-deficient mutant 
was converted to bacilysin production indicating that mutation in bacD blocked the 
conversion of anticapsin to bacilysin; therefore, blocked the gene to encode the 
proposed ligase function (Steinborn, et al. 2005). In addition to this report, by in 
silico screening, in 2005, it was found that BacD protein catalyzes the formation of 
dipeptide forming L-alanyl-L-glutamine from L-alanine and L-glutamine in an ATP 
dependent manner. ADP and phosphate were formed in the ligation reaction 
catalyzed by BacD protein (Tabata et al., 2005), whereas aminoacyl-tRNA 
synthetase or the adenylation domain of NRPS forms acyl-AMP as a reaction 
products (Cane et al. 1999). Besides, BacD protein does not include any motif of 
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aminoacyl-tRNA synthetase or the adenylation domain of NRPS (Tabata et al., 
2005). So that, in accordance with the previous research (Sakajoh et al. 1987), it has 
been proved once more again that bacilysin synthesizing reaction is carried out on a 
amino acid ligase, which is now known as BacD protein encoded by bacD gene, 
rather than NRPS-like manner (Tabata et al., 2005; Steinborn, et al. 2005; Yazgan et 
al., 2001).  
By the way, over-production of recombinant anticapsin in ∆(ywfA-bacABCDE)::catR 
mutant strain caused cell protoplasting and later cell lysis. This demonstrated that 
chromosomal bacE gene is responsible in self-protection to bacilysin (Steinborn, et 
al. 2005).  
To sum up, bacABC genes carry the anticapsin production functions, while the bacD 
and bacE genes encode the functions of amino acid ligation and self-protection to 
bacilysin, respectively (Inaoka et al., 2003; Steinborn et al. 2005; Tabata et al., 
2005). 
1.5.2. Genetic Regulation of Bacilysin  
When it comes to the bacilysin, it has been proved that even the bacilysin is under 
the regulation of abrB and spo0A genes. Insertional mutation in abrB gene resulted 
in an increase in bacilysin production, indicating that bacilysin synthesis is under the 
negative control of abrB gene. In the same research, spo0A blocked mutant cells 
could not produce bacilysin (Yazgan et al., 2003). 
Bacilysin production is regulated on different levels negatively by GTP via the 
transcriptional regulator CodY and AbrB (Mascher et. al., 2004 and Yazgan et al., 
2003). Distruption of phrC, comA and oppA by Tn10 transposon mutagenesis and 
resulting bacilysin-negative mutants demonstrated the reationship between the 
Spo0K dependent quorum sensing regulation system and bacilysin biosynthesis in B. 
subtilis (Yazgan et al., 2001). In other words, bacilysin biosynthesis is directly 
related with the ComA and PhrC in a Spo0K-dependent manner and under the 
regulation of quorum sensing mechanism in B. subtilis (Yazgan et al., 2001). 
Moreover, the second pathway of quorum sensing system called as two-component 
signal transduction system was also found to be essential for bacilysin biosythesis 
since the introduction of comQ::cat mutation resulted in the elimination of bacilysin 
biosynthesis (Yazgan et al., 2003).    
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Recent researches have showed that disruption of srfA operon in the bacilysin 
producer caused the bacilysin-negative phenotype. Therefore, it is thought that 
bacilysin and surfactin biosynthesis is under control of same regulation factors 
(Yazgan et al., 2003).   
Positive regulation occurs by guanonsine 5'-diphosphate 3'-diphosphate (ppGpp) and 
a quorum-sensing mechanism through the peptide pheromone PhrC (Inaoka et al., 
2003; Yazgan et al., 2001). 
1.6. Electromobility Shift Assay (EMSA) 
Electromobility shift assay, which is also called as mobility shift electrophoresis or 
gel retardation assay is a common electrophorosis technique which is used in 
molecular biology for the protein-DNA or protein-RNA interactions. This technique 
determine whether a protein or protein mixture binds to its target DNA (or RNA) or 
not. While protein-RNA (or protein-DNA) mixture is run on a agarose or 
polyacrylamide gel for a period, control lane is run only with DNA probe (or RNA 
probe). EMSA protocol can be divided three major steps; labelling and isolation of 
the nucleic acids (DNA or RNA), incubation of protein-DNA binding reaction,  and 
finally running the sample on a native poliacrylamide or agarose gel (Figure 1.6). If 
the protein has the capability of binding to its target, the lane with the protein-DNA 
will move more slowly compared the control lane which includes only the free DNA 
and therefore, cause a shift detection (Hellman and Fried,2007; Holden and  Tacon, 
2010). Molecule size, molecular weight and charge are the considerable parameters 
that make samples run on nondenaturing gel matrix in different mobilities 
(Gaudreault, M. et al, 2009; Hellman and Fried,2007). 
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Fig. 1.6: A schematic diagram of EMSA (Holden and  Tacon, 2010). 
1.7. DNase I Footprinting Assay 
Transcription of DNA to RNA requires many factors including enhancer, silencer 
elements and  transcription factors that bind to regulatory regions on DNA. So as to 
identify the DNA regions on which  trans-acting molecules bind, recently being 
common method called DNase footprinting assay has been employed mostly. In this 
assay, one end of the double-stranded DNA is labelled wtih radiactive molecules or a 
fluorescein dyes. Labelled DNA is incubated with the DNA-binding protein and then 
the labelled DNA in sample is cut by chemical (hydroxyl radicals) or enzymatic 
cleavage (DNase 1) agent. Resulted DNA fragments are separated on sequencing gel. 
There will be gaps on the sequencing gel due to the binding proteins which bind to 
DNA and protect the binding region of DNA being cleaved by DNase 1 or hydroxyl 
radicals. The protected region of DNA will be missing (Figure 1.7) and  will be an 
evident as a gap which also called as footprint on the separation gel (Hampshire, et 
al. 2007; Wilson et al., 2001). Recently, instead of sequencing gel, capillary 
electrophoresis is used for separation of the DNA fragments (Wilson et al., 2001; 
Zianni, 2006).  
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Fig. 1.7: Schematic representation of  footprinting assay (Hampshire et al., 2007). 
 
1.8. Aim of the Project 
 
There are strong evidences showing the essential roles of  AbrB and Spo0A on the 
biosynthesis of antibiotics and toxins in Bacillus species. It has been demonstrated 
that even the bacilysin is under the regulatin of abrB and spo0A genes. After the 
recent findings concerning the responsibility of yvfI gene whose product is similar to 
transcriptional regulator (GntR family) in bacilysin production in Bacillus subtilis 
PY79 strain, there needs to find the other genes  regulating bacilysin production 
through yvfI gene, since any gene involved in the regulation of yvfI is also 
responsible in the regulation of bacilysin production indirectly. Subject to the 
foregoing provisions, our studies are focused on determining the cis-elements in the 
promoter region of the B.subtilis yvfI gene to which the candidate regulatory proteins 
are bound.  
For this purpose, B. subtilis yvfI promoter was examined using DBTBS database and 
putative binding sites on yvfI promoter were found for AbrB and Spo0A regulatory 
proteins. After the production of purified Spo0A and AbrB recombinant proteins in 
E. coli, DNA Mobility Shift Assay (EMSA)  and Capillary –Based DNase I 
Footprinting Assay have been employed in order to find the exact binding sites of 
AbrB and Spo0A regulatory proteins on yvfI promoter and to provide further insight 
into the regulation of bacilysin by the means of transcriptional regulation of yvfI 
gene.  
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2. MATERIALS and METHODS 
2.1. Materials  
2.1.1. Bacterial Strains 
 
Table 2.1: Bacterial strains used through the project 
Strain Genotype Source 
Bacillus subtilis PY79 
Wild type, BSP cured 
prototrophic derivative of 
B.subtilis 168 
P.Youngman 
E.coli Top10F’ 
[lacIq Tn10(Tetr)], mcrA ∆(mrr-
hsdRMS-mcrBC), 
f80lacZ∆M15 ∆lacX74, deoR, 
recA1, araD139 
∆(ara-leu)7697, galU, galK,rpsL 
(Strr), endA1, nupG 
M.A.Marahiel 
 
 
2.1.2. Bacterial Culture Media 
The compositions and preparation of bacterial culture media are given in Appendix 
A. 
2.1.3. Buffers and Solutions 
The compositions and preparation of buffers and solutions are given in Appendix B. 
2.1.4. Chemicals and Enzymes 
The chemicals and enzymes used and their suppliers are given in Appendix C. 
2.1.5. Laboratory Equipment 
The laboratory equipment used during the project is listed in Appendix G. 
 
 
16
2.1.6. Maintenance of Bacterial Strains 
 
PY79 strain of B.subtilis was grown in Luira-Bertani (LB) liquid medium and kept 
on Luira-Bertani (LB) agar plates. E.coli strains were kept on Luira-Bertani (LB) 
agar plates. All cultures were stored at 4 C°.  
 
2.2. Methods 
2.2.1. Construction of pJET-abrB and pJET-spo0A Cloning Vectors 
2.2.1.1. Amplification of abrB and spo0A Genes by Polymerase Chain Reaction  
The oligonucleotide primers abrB F1,  abrB R1, spo0A F1 and  spo0A R1 primers 
given below are the forward and the reverse primers for the amplification of abrB 
and spo0A genes to be cloned into pJET 1.2 / Blunt Cloning Vector, respectively. 
Underlined sequences represent recognition sites for BamHI and NcoI restriction 
enzymes on forward and reverse primers respectively.  
 
abrB F1 : 5' – CGGCCATGGGTATGTTTATGAAATCTACTGGT – 3' 
abrB R1 : 5' – GCCGGATCCTTTAAGGTTTTGAAGCTG – 3' 
spo0A F1: 5' – CGGCCATGGGTGAGAAAATTAAAGTTTGT– 3' 
spo0A R1: 5'– GCCGGATCCAGAAGCCTTATGCTCTAACCT – 3' 
 
PCR components given in Table 2.2 were combined in a 0.2 ml tubes on ice.  
  
Table 2.2 : The volume of PCR components 
 
 
 
 
 
 
 
 
 
 
 
Component Exp. (-) Control 
dH2O 40,5 µl 42,5 µl 
10X pfu Buffer 5 µl 5 µl 
dNTP 1 µl 1 µl 
F Primer 0,5 µl 0,5 µl 
R Primer 0,5 µl 0,5 µl 
Template DNA (PY79) 2 µl - 
pfu DNA polymerase 0,5 µl 0,5 µl 
Total 50 µl 50 µl 
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The final concentrations of the primers and dNTP mix were 0,5 µM and 0,2 µM 
respectively. Chromosomal DNA of B.subtilis PY79 strain was used as template. 
PCR reaction was performed according to the following cycling program, enabling 
the heated lid: 
 
PCR conditions 
 
95 °C,  3 min           1 cycle (Initial denaturation) 
 
95 °C,  1 min 
55 °C,  1 min         30 cycles  +  72 °C, 10 min       1 cycle  (Final extension) 
72 °C,  2 min 
 
2.2.1.2. Agarose Gel Electrophoresis of PCR Products 
After the amplification of the desired genes, PCR products were analyzed on agarose 
gel electrophoresis. Firstly, for %1 gel, 0.5 gr agarose was added in 50 ml 0.5X TAE 
buffer (Appendix B) and then gel solution was boiled in a microwave until the 
agarose was completely dissolved. After cooling the solution to about 60°C, 
ethidium bromide was added to the gel solution to a final concentration of 0.5 ug/ml. 
Then, gel solution was poured into gel casting tray and a proper comb was placed in 
gel tray. After the gel had been solidified, the comb was removed and gel was placed 
in electrophoresis chamber containing the appropriate amount of 0.5X TAE buffer 
(Appendix B). An appropriate molecular weight marker (Marker 9, Fermentas) and 
PCR product samples that were mixed with the 6X loading dye depending on volume 
were pipeted into the gel wells. Gel was run at 80 V for 20 min. EtBr-stained DNA 
bands were visualized by UV trans-illuminator. 
 
2.2.1.3. Ligation of the PCR Product Into pJET 1.2 / Blunt Cloning Vector           
For the ligation of the PCR products into pJET 1.2/Blunt Cloning Vector, CloneJET 
PCR Cloning Kit (Fermentas) was used and the following reaction was set up for 
each PCR product. All components were added into a 1.5 ml eppendorf tube 
according to volumes that are given in Table 2.3. The eppendorf tube including all 
components was incubated at 25 oC for 30 min.  
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Table 2.3 : Volume of components used in ligation of the                                                                                 
                         PCR product into pJET 1.2 / blunt cloning vector 
Component Volume/reaction 
pJET1.2/blunt Cloning Vector (50 ng/ul) 1 µl 
PCR product 3 µl 
2X Reaction Buffer 10 µl 
T4 DNA Ligase 1 ul 
Water, nuclease-free 5 µl 
Total volume 20 µl 
 
Thereby, blunt-ended PCR products generated with the pfu DNA polymerase were 
ligated directly into the cloning vector. The newly contructed vectors were renamed 
as pJET-abrB and pJET-spo0A. 
2.2.1.4. Preparation of Electrocompotent E.coli Top 10F' Cells  
To make the electrocompotent cells, one night before E.coli Top10F' strain was 
inoculated into 500 ml 2xYT broth (Tet 20 µg/ml) with a 1/100 dilution rate and 
incubated at 37°C until OD600 reached 0.6. After incubation, the flask containing 
E.coli Top10F' strain was stayed on ice for 30 min. Then, cells were centrifuged in a 
50 ml ependorf tube at 4000 rpm for 15 minutes. Supernatant was removed and pellet 
was resuspended in 40 ml of cold dH2O and centrifuged at 4000 rpm for 15 min. 
After having removed the supernatant, the pellet was again resuspended in 20 ml of 
cold dH2O in a 50 ml tube at 4000 rpm for 15 minutes. Then supernatant was 
discarded and cells were resuspended in 1 ml of 10% glycerol. Aliquots were 
prepared as 40 µl volume in the 1.5 ml eppendorf tubes. The samples were stored at  
-80°C. 
2.2.1.5. Transformation of pJET-abrB and pJET-spo0A to Electrocompotent 
E.coli Top10 Cells 
Initially, electrocompotent E.coli top 10 cells were thawed on ice. 10 µl of the   
pJET-abrB ligation sample which had been obtained in section 2.2.1.3, was added to 
the tube containing 40 µl E.coli top 10F’ cells and all together were transferred into 
the electroporater tube which had been cooled before on ice for 10 min. Then, the 
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electroporator tube was placed into electroporation machine and transformation 
processed at 1800V for 2-3 second. After addition of 1 ml of LB broth to the 
electroporator tube, the mixture was transferred to a 2 ml eppendorf tube and 
incubated at 37°C for 1 h. For negative control, 1 ml LB broth was added into the 
another 2 ml eppendorf tube containing only the compotent cells. After 1 hour 
incubation of both tubes at 37 °C, the tubes were centrifuged for 10 min. at 5000 rpm 
so as to harvest cells. The supernatants were removed and the pellets were 
resuspended in 100 µl of 0.85% NaCl2. 100 µl of each suspention was spread out on 
LB plates containing ampicilin (100 µg/ml). Agar plates were incubated at 37°C for 
16 hours. Colonies are selected and inoculated into LB broth with amp (100µg/ml) 
and also sketched to a LB agar plate with amp (100µg/ml). Both agar plate and broth 
cultures were incubated at 37°C for 16 hours. 
All the protocol has been done exactly in the same way for the transformation of the 
pJET-spo0A to E.coli Top10 cells.  
2.2.1.6. Plasmid DNA Isolation  
Plasmid DNA isolation of the cultures incubated for 16 hours in LB broth was 
applied through using the buffers and solutions of the QIAquick Plasmid DNA 
Isolation Kit (Qiagen). 
After centrifugation in 2 ml ependorf tubes at 13000 rpm for 5 minute, bacterial cells 
were harvested. The supernatant was removed and the pellet was resuspended in 300 
µl P1 buffer completely by vortexing and pipetting up and down. 300 µl P2 buffer 
was added and the suspention was mixed by inverting tubes 4-6 times before the 
incubation at room temperature for 5 minutes. Then, 300 µl P3 buffer was added into 
the tubes and mixed by inverting until lysate is no longer viscous. After that, 
ependorf tubes were stayed on ice for 15 minutes before centrifugation at 13000 rpm 
for 15 minutes. With the help of pipette, the supernatant part of the suspention was 
put to new 1.5 ml eppendorf tubes. According to the volume of the supernatant, 0.7 
volume of isopropanol was added into the tubes and centrifuged at 13000 rpm for 30 
minutes. After the removal of supernatant, 1ml of 70% ethanol was added and 
centrifugation at 13000 rpm for 5 minutes was applied to wash the pellets. 
Supernatant was removed and pellets were dried out at 37°C for 15 minutes for the 
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complete removal of ethanol by evaporation. Finally, 15 µl of EB buffer was added 
and the tubes were incubated at 37°C for 15 minutes at 350 rpm.  
2.2.1.7. Agarose Gel Electrophoresis 
% 0.8 agarose gel was prepared to check the result of the plasmid isolation. Firstly, 
0.4 gr agarose was added in 50 ml of 0.5X TAE buffer (Appendix B), then gel was 
boiled in a microwave oven until completely melted. After cooling the solution, to 
facilitate visualization of DNA after electrophoresis, a final concentration of 0.5 
ug/ml of ethidium bromide was added to the gel solution. Then it was poured into a 
casting tray containing a sample comb and allowed to solidify at room temperature. 
After the solidification, the comb was removed and plasmid DNA samples and 
moleculer weight Marker 3 (Fermentas, Appendix D) were loaded into the gel wells 
after all samples were mixed with 6X gel loading dye depending on volume. Gel was 
run at 80V for 25 min. and plasmids DNA bands were visualized by UV trans-
illuminator. 
 
2.2.2. Construction of pQE60-abrB and pQE60-spo0A Expression Vectors 
2.2.2.1. Enzymatic Digestion 
Concentrated plasmids having the different conformations on agarose gels were 
chosen for enzymatic digestion. Following reaction including the components as 
shown in Table 2.4 was set up for each vector construct, pJET-abrB and pJET-spo0A 
and digestion proceeded with  BamHI and NcoI restriction enzymes at 37°C for 3 
hours in order to check whether abrB and spo0A genes had been cloned into the 
pJET1.2/blunt Cloning Vector. Then enzymes were denaturated at 65°C for 20 min.  
 
Table 2.4 : The components of the enzymatic digestion reaction 
Component Volume/reaction 
pJET-abrB (or pJET-spo0A ) 2 µl 
Buffer 10 X Tango 2 µl 
BamHI 0.25 µl 
NcoI 0.25 ul 
dH2O 15.5 µl 
Total volume 20 µl 
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For constructing expression vectors containing the abrB (or spo0A) gene, pQE60 
Expression Vector, pJET-abrB and pJET-spo0A were digested with same restriction 
enzyme, BamHI and NcoI in the same conditions provided for pJET1.2/blunt Cloning 
Vector. As fragments including abrB and spo0A genes and pQE60 Expression 
Vector both were digested with same restriction enzymes, direct ligation of abrB and 
spo0A genes to pQE60 Expression Vector would be applied. The components of the 
reactions are given in Table 2.5 and Table 2.6. 
 
Table 2.5 : The components of the pJET-abrB enzymatic digestion 
Component Volume/reaction 
pJET-abrB (or pJET-spo0A ) 9 µl 
Buffer 10 X Tango 4 µl 
BamHI 0.5 µl 
NcoI 0.5 ul 
dH2O 26 µl 
Total volume 40 µl 
 
 
Table 2.6 : The components of the pQE60 enzymatic digestion 
Component Volume/reaction 
pQE60 Expression Vector 9 µl 
Buffer 10 X Tango 4 µl 
BamHI 0.5 µl 
NcoI 0.5 ul 
dH2O 26 µl 
Total volume 40 µl 
 
 
2.2.2.2. Gel Extraction 
After 3 hours incubation of both reactions at 37°C in thermomixer, the samples that 
had been digested by restriction enzymes were loaded on agarose gel in order to 
isolate only the linearized pQE60  and DNA fragments including abrB and spo0A 
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genes from the rest of the DNA fragments for direct ligation. In that purpose,   
QIAquick Gel Extraction Kit (Qiagen) was used for the gel extraction of the 
enzymatic digestion. The fragments pQE60 in lineer form and DNA fragments 
including abrB and spo0A genes were excised from the gel and put into the different 
ependorf tubes. After that, depending on the weight of the fragments, 3 volumes of 
buffer QG were added. In order to dissolve the gels, tubes were incubated for 10 
minutes at 50°C by shortly vortexing every 2-3 minutes, until the gels were dissolved 
completely. Following, 1 volume of isopropanol was added into tubes. The samples 
were mixed by inverting several times and then applied to the QIAquick column for 
centrifugation at 13000 rpm for 1 minute. Then the flow through was discarded and 
the QIAquick column was placed back into the same collection tube. After addition 
of 500 µl buffer QG, the samples were centrifuged at 13000 rpm for 1 minute. Later, 
the flow through was removed and 750 µl buffer PE was added so as to wash the 
samples. The columns were standed for 2-5 minutes and then centrifuged at 13000 
rpm for 1 minute. For complete removal of ethanol, the columns were centrifuged at 
13000 rpm for an additional 1 minute. Finally, the columns were placed into clean 2 
ml microfuge tubes and 40 µl  of EB buffer was added to the center of the  QIAquick 
membranes. The samples were standed for 1 minute and then centrifuged for 1 
minute at 13000 rpm. The final solutions contaning the linearized pQE60 expression 
vector  and DNA fragments including abrB and spo0A genes in discrete tubes were 
stored at  –20 °C until the next ligation step.  
 
2.2.2.3. Ligation of abrB and spo0A Genes Into pQE60 Expression Vector 
To begin up, 9 µl sample of DNA fragment containing abrB gene as insert and 2 µl 
pQE60 vector were added into an eppendorf tube and incubated at 65°C for 5 
minutes. After that, the tube was cooled on ice. Before having started the ligation, 
eppendorf tube was spanned down so as to collect the whole mixture at bottom of the 
tube. Following, 2µl of ligation 10 X buffer, 2µl of T4 DNA ligase (Roche), 6µl of 
dH2O were added into the same eppendorf tube. The mixture was again spanned 
down for a quick spin and incubated at 16°C for 16 hours. After incubation, the tube 
was incubated at 65°C for 10 minutes for denaturation of the enzyme. Same protocol 
was done exactly in the same way for the ligation of spo0A gene into linearized 
pQE60 expression vector. The newly contructed vectors were renamed as pQE60-
abrB and pQE60-spo0A. 
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2.2.2.4. Transformation of pQE60-abrB and pQE60-spo0A to Electrocompotent 
E.coli Top10 Cells 
40 µl aliquot of electrocompotent E.coli top 10 cells was thawed on ice. 10 µl of the 
pQE60-abrB ligation sample which had been obtained in section 2.2.2.5, was added 
to the tube containing 40 µl E.coli top 10F’ cells and all together were transferred 
into the electroporation cuvette which had been cooled on ice before. Then, the 
electroporator cuvette was placed into electroporation machine and transformation 
processed at 1800V for 2-3 second. After addition of 1 ml of LB broth to the 
electroporator cuvette, the mixture was mixed gently by pipetting up-down and 
transferred to a 2 ml eppendorf tube for the incubation at 37°C for 1 h. For negative 
control, 1 ml LB broth was added into the another 2 ml eppendorf tube containing 
only the compotent cells. After 1 hour incubation of both tubes at 37 °C, the tubes 
were centrifuged for 10 min. at 5000 rpm so as to harvest cells. The supernatants 
were removed and the pellets were resuspended in 100 µl of 0.85% NaCl2. 100 µl of 
each suspention was spread out on LB plates containing 100 µg/ml final 
concentration of ampicilin. Agar plates were incubated at 37°C for 16 hours. 
Colonies are selected and inoculated into LB broth with amp (100µg/ml) and also 
sketched to a LB agar plate with amp (100µg/ml). Both agar plate and broth cultures 
were incubated at 37°C for 16 hours. 
All the protocol has been done exactly in the same way for the transformation of the 
pQE60-spo0A vector to E.coli Top10 cells.  
2.2.3. Expression and Purification of 6xHis-tagged Spo0A and AbrB Proteins 
2.2.3.1. Expression of 6xHis-tagged AbrB and 6xHis-tagged Spo0A  Proteins 
Selected recombinant clones from each transformation were inoculated into the fresh 
10 ml LB medium containing 100 ug/ ml amp and incubated overnight at 37°C at 
200 rpm shaking. After that 3 ml of the each culture was transferred to fresh 100 ml 
LB medium with 100 ug/ ml amp and cells were grown until the the OD600 reaches 
0,55. Immediately before the induction, 2 ml sample from each culture was taken 
into new tubes and cells collected by centrifugation at 4000 g for 20 min at 4°C and 
were stored at -80°C until the purification step. This samples were the noninduced 
controls. In order to induce T7 RNA polymerase, and hopefully our target proteins, 
AbrB and Spo0A, IPTG was added to a final concentration of 1 uM and cells were 
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grown for an additional 5 hours at 30°C with gentle shaking at 200 rpm. Then, cells 
were harvested by centrifugation at 4000 g for 20 min at 4°C and were stored at -
80°C until the purification step. 
 
2.2.3.2. Purification of 6xHis-tagged AbrB and 6xHis-tagged Spo0A Proteins 
Since our overexpressed proteins were soluble proteins, they were purified  under the 
native conditions. Also, to prevent the degradation of the proteins, cells and proteins 
solutions were kept at 0 - 4°C at all times and an air-cooled centrifuge with 
swinging-bucket rotor was used. 
 
1. Cell pellets obtained in previous step by centrifugation before (noninduced 
samples) and after induction (induced samples) were thawed on ice for 15 
min. Then, pellets of noninduced and induced samples were resuspended in 
100ul and 10 ml lysis buffer, respectively (Appendix B). For further cell 
distruption, lysozyme to a final  concentration of 0.2 mg/ml was added to 
each solution and incubated on ice for 30 min. So as to lyse the cells as much 
as possible, sonicator equipped with a microtip was used with a 10 s cooling 
period between six 10 s bursts at 70 W.  
 
20  ul of each cell lysate (induced AbrB, induced Spo0A, noninduced AbrB 
and noninduced Spo0A) was kept in 1.5 ml tubes for subsequent SDS-PAGE 
analysis. These cell lysates contain all the proteins expressed by E.coli, so 
that marked as total homogenate. 
 
2. Insoluble materials of induced AbrB and induced Spo0A cell lysates were 
removed from the soluble fraction by centrifugation at 4°C for 30 min at 
4000g and supernatant fraction of each culture was collected into fresh tubes. 
 
20  ul of each supernatant solution (induced AbrB, induced Spo0A) was kept 
in 1.5 ml tube for subsequent SDS-PAGE analysis. These samples contain all 
the soluble proteins expressed by E.coli, so that marked as total supernatant. 
 
3. 1 ml of the 50% slurry of Ni-NTA resin was added to each tube and mixed 
gently by shaking at 50 rpm on a rotary shaker  for 30 min at 4°C. Then the 
tubes were centrifuged at 1000 g for 1 min to pellet the resin.  
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20 ul of each supernatant solution was transferred into 1.5 ml tube for 
subsequent SDS-PAGE analysis. These supernatant solutions contain all the 
proteins which have not bound to the resin, so that marked as unbound 
samples. Remaining supernatants were discarded. 
 
4. Ni-NTA resins were washed twice with 1 ml of wash buffer (Appendix B). 
Tubes were centrifuged for 1 min at 1000 g between each wash step and the 
supernatants were carefully removed. 
 
20 ul of each supernatant solution was kept in 1.5 ml tube for subsequent 
SDS-PAGE analysis. These supernatant solutions were marked as wash 1 and 
wash 2.  
 
5. Our interested proteins, AbrB and Spo0A, were eluted 3 times with 500 ul 
elution buffer (Appendix B). Tubes were centrifuged for 1 min at 1000 g 
between each elution step and the supernatants were carefully transferred into 
new fresh tubes. 
 
20 ul of each supernatant solution was kept in 1.5 ml tube for subsequent 
SDS-PAGE analysis. These supernatant solutions contain our target proteins 
and so that marked as elution 1, elution 2 and elution 3.  
 
Thereby, by the way of metal chelation affinity between the Ni2+ metal ions on NTA 
and  imidazole ring on histidine residues (6xHis tag), overexpressed recombinant 
Spo0A and AbrB proteins were purified for the electromobility shift and Dnase I 
footprinting assays. 
 
2.2.3.3. SDS-Polyacrylamide Gel Electrophoresis of AbrB and Spo0A  
In order to analyze the samples obtained during purification steps (section 2.2.3.2) 
and purification quality of the AbrB and Spo0A proteins, two SDS polyacrylamide 
gels were prepared one for AbrB, and other one for Spo0A protein analysis by 
mixing the ingredients needed for % 12 gel as shown in Table 2.7 and Table 2.8.  
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Table 2.7 : Components of Lower Resolving Gel (12 % Acrylamide/Bis-acrylamide) 
Components Volume 
H2O 3.3 ml 
1.5 M Tris-HCI (pH:8.8) 2.5 ml 
SDS (10%, w/v) 0.1 ml 
Acrylamide:bis-acrylamide (29:1) (30%, w/v) 4.0 ml 
Ammonium Persulfate (APS) (10%, w/v) 0.1 ml 
TEMED 10 ul 
Total 10 ml 
 
Prepared solution was poured into the gel casting forms provided that leaving 2 cm 
below the bottom of the comb for the upper stacking gels. Top of the gels were 
layered with 200 ul isopropanol to remove the bubbles. After the polymerization of 
the lower resolving gels, isopropanol was washed out completely.  
 
Table 2.8 : Components  of  Upper Stacking Gel (5 %  Acrylamide/Bis-acrylamide) 
Components  Volume 
H2O 1.4 ml 
1 M Tris-HCI (pH:6.8) 0.25 ml 
SDS (10%, w/v) 0.02 ml 
Acrylamide:bis-acrylamide (29:1) (30%, w/v) 0.33 ml 
Ammonium Persulfate (APS) (10%, w/v) 0.02 ml 
TEMED 6 ul 
Total  2 ml 
 
Prepared upper stacking gel solution was poured on the top of the lower resolving 
gels and combs were inserted. After this, gels were allowed for complete 
polymerization. 12 ul of each sample obtained in purification steps were mixed with 
6 ul of 3X SDS loading dye (Appendix B) and boiled for 5 min at 95 °C for protein 
denaturation. After loading all the samples and protein marker (Fermentas, Appendix 
D) to the gel lanes, gels were run at 80 volt for upper stacking gels and 140 volt for 
lower resolving gels until the loading dyes reached the bottom of the gels. 
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Visualization of the protein bands were accomplished by staining the gels with 100 
ml of gel stain solution (Appendix B) with shaking at 40 rpm for 1 hour at 37 °C. 
Finally, gels were destained by 100 ml of gel destain solution (Appendix B) with 
gentle shaking at 30 rpm for 2 hours at 37 °C. 
 
2.2.4. Electromobility Shift Assay of AbrB and Spo0A Proteins 
2.2.4.1. Cloning of yvfI Promoter Into  pJET 1.2 / Blunt Cloning Vector 
The oligonucleotide primers yvfI P/ F1  and  yvfI P/ R1 primers given below are the 
forward and the reverse primers for the amplification of the DNA fragments 
including the yvfI promoter to be cloned, respectively.  
 
yvfI P/ F1  : 5' – CGGCCATGGGTATGTTTATGAAATCTACTGGT – 3' 
yvfI P/ R1  : 5' – GCCGGATCCTTTAAGGTTTTGAAGCTG – 3' 
 
Underlined sequences represent recognition sites for EcoRI and BamHI restriction 
enzymes on forward and reverse primers respectively.  
 
                            Table 2.9 : The volume of PCR components                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
PCR components given in Table 2.9 were combined in a 0.2 ml tubes on ice. PCR 
reaction was performed according to the following cycling program, enabling the 
heated lid: 
 
 
Component  Exp. (-) Control 
dH2O 40,5 µl 42,5 µl 
10X pfu Buffer 5 µl 5 µl 
dNTP 1 µl 1 µl 
F Primer 0,5 µl 0,5 µl 
R Primer 0,5 µl 0,5 µl 
Template  2 µl - 
pfu DNA polymerase 0,5 µl 0,5 µl 
Total  50 µl 50 µl 
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PCR conditions 
 
95 °C,  3 min           1 cycle (Initial denaturation) 
 
95 °C,  1 min 
55 °C,  1 min           30 cycles  +  72 °C, 10 min       1 cycle  (Final extension) 
72 °C,  2 min 
 
The final concentrations of the primers and dNTP mix were 0,5 µM and 0,2 µM 
respectively. Chromosomal DNA of B.subtilis PY79 strain was used as template.  
Having performed the PCR reaction, components needed for cloning of the yvfI 
promoter into  pJET 1.2 / Blunt Cloning Vector were added into a 1.5 ml eppendorf 
tube according to volumes that was given in Table 2.10. The eppendorf tube 
including all components was incubated at 25 oC for 30 min. for ligation and then 
ligase was denatured at 70 °C for 10 minutes. 
                 
Table 2.10 : Volume of components used in ligation of the 
                             PCR product into pJET 1.2 / blunt Cloning Vector 
 Component Volume/reaction 
pJET1.2/blunt Cloning Vector (50 ng/ul) 1 µl 
PCR product 3 µl 
2X Reaction Buffer 10 µl 
T4 DNA Ligase 1 ul 
Water, nuclease-free 5 µl 
Total volume 20 µl 
 
 
After the ligation reaction, the newly constructed plasmid renamed as pJET-
yvfIprom. Bacterial transformation and plasmid isolation of the  pJET-yvfIprom was  
performed exactly in the same way as mentioned before in section 2.2.1.5 and 
2.2.1.6, respectively. pJET-yvfIprom plasmid was used as a template for the 
synthesis of unlabelled oligonucleotide and FAM-labelled probe, needed for 
subsequent electromobility shift and DNase I footprinting assays, respectively. 
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2.2.4.2. yvfI Promoter Synthesis from pJET-yvfIprom for EMSA  
Double-stranded oligonucleotides that encompasses bases –396 to + 18 relative to the 
translational start point of yvfI (Appendix F) were synthesized by PCR from the 
pJET-yvfIprom using following primers: 
 
yvfI E/ F  : 5' – CTGGCGCCATATGTAAGCGGT – 3' 
yvfI E/ R  : 5' – GCCTTCTCCCAGTTTCAT – 3' 
 
The final concentrations of the primers and dNTP mix were 0,5 µM and 0,2 µM 
respectively. pJET-yvfIprom was used as template.   
 
                            Table 2.11 : The volume of PCR components 
 
 
 
 
 
  
 
 
 
 
 
PCR components given in Table 2.11 were combined in a 0.2 ml tubes on ice. PCR 
reaction was performed for 30 cycles under the following conditions, enabling the 
heated lid: 
 
PCR conditions 
 
95 °C,  2 min           1 cycle (Initial denaturation) 
95 °C,  1 min 
55 °C,  1 min           30 cycles  +  72 °C, 10 min       1 cycle  (Final extension) 
72 °C,  1 min 
Component  Exp.      (-) Control 
dH2O 40,5 µl 42,5 µl 
10X pfu Buffer 5 µl 5 µl 
dNTP 1 µl 1 µl 
F Primer 0,5 µl 0,5 µl 
R Primer 0,5 µl 0,5 µl 
Template ( pJET-yvfIprom) 2 µl - 
pfu DNA polymerase 0,5 µl 0,5 µl 
Total  50 µl 50 µl 
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As a result of the PCR reaction, amplification of the 414 bp DNA fragment that 
encompasses bases –396 to +18 of yvfI (according to the translational start point of 
yvfI) was accomplished. 
  
2.2.4.3. Purification of the yvfI Promoter 
So as to purify the PCR product, QIAquick PCR Purification Kit (Qiagen) was used.  
1. 250 ml of the Buffer PBI was added to 50 ml of PCR product and mixed. 
2. Sample was applied to the  QIAquick column and centrifuged 1 min at 13.000 
rpm. 
3. Flow-through was discarded from the tube and QIAquick column was placed 
into the same collection tube. 
4. 0.75 ml of the Buffer PE was added to the QIAquick column and centrifuged 
1 min at 13.000 rpm for washing the sample. 
5. Flow-through was discarded from the collection tube and QIAquick column 
was placed back in the same collection tube. Sample was centrifuged at 
13.000 rpm for for an additional 1 min to remove the ethanol from the sample 
completely. 
6. After replacing the collection tube with a clean 1.5 ml microcentrifuge tube, 
40 ul of ddH2O (pH:7.0-8.5) was added to the center of the QIAquick 
membrane and the  sample was centrifuged at 13.000 rpm for 1 min.  
 
2.2.4.4. Binding Reactions of Protein-yvfI Promoter DNA for EMSA 
Binding reactions for Spo0A-yvfI promoter were employed by incubating varying 
amounts of Spo0A proteins ranging from 0 to 60 ug with 1 ug of DNA fragments  
(414 bp DNA fragments consisting of bases –396 to + 18 relative to the  translational 
start point of the yvfI gene, Appendix F) and 2 µg of Poly(dI-dC)  as a non-specific 
competitor  DNA at  room temperature for 25 min in binding buffer A [20 mM 
Hepes, 1 mM EDTA, 10 mM (NH)4SO4, 1 mM DTT, %0,2 Tween 20 and 30 mM 
KCI, pH:8.0]. The reaction mixtures in 0.2 ml tubes were completed to a final 
volume of 25 µL with ddH2O after combining all the components as shown in Table 
2.12. Control tube contained BSA protein instead of AbrB protein.  
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Table 2.12 : Binding Reactions for Electromobility Shift Assay of Spo0A Protein 
 1 2 3 4 5 6 7 8 
DNA 
fragments 
1 ug 1 ug 1 ug 1 ug 1 ug 1 ug 1 ug 1 ug 
Poly(dI-dC) 2 ug 2 ug 2 ug 2 ug 2 ug 2 ug 2 ug 2 ug 
Spo0A 
protein 
- - 10ug 20ug 30ug 40ug 50ug 60ug 
BSA - 20ug - - - - - - 
5X binding 
buffer A 
5 ul 5 ul 5 ul 5 ul 5 ul 5 ul 5 ul 5 ul 
 
 
Binding reactions of AbrB-yvfI promoter were performed by incubating varying 
amounts of AbrB proteins ranging from 0 to 42 ug with 1 ug of DNA fragments  
(414 bp DNA fragments consisting of bases –396 to + 18 in relation to the 
translational start point of the yvfI gene, Appendix F) and 2 ug of Poly(dI-dC)  as a 
non-specific competitor  DNA at  room temperature for 20 min in binding buffer B 
(50 mM KCI, 5 mM MgCI2,, 0.1 mM EDTA, 1 mM DTT and % 8  glycerol, 
pH:8.0). The reaction mixtures in 0.2 ml tubes were completed to a final volume of 
25 µL with ddH2O after combining all the components in reaction tubes as shown in 
Table 2.13. Control tube contained BSA protein instead of AbrB protein. 
 
Table 2.13 : Binding Reactions for Electromobility Shift Assay of AbrB Protein 
 1 2 3 4 5 6 7 8 9 
DNA 
fragments 
1 ug 1 ug 1 ug 1 ug 1 ug 1 ug 1 ug 1 ug 1 ug 
Poly      
(dI-dC) 
2 ug 2 ug 2 ug 2 ug 2 ug 2 ug 2 ug 2 ug 2 ug 
AbrB 
protein 
- - 6ug 12ug 18ug 24ug 30ug 36ug 42ug 
BSA - 16ug - - - - - - - 
5X binding 
buffer B 
5 ul 5 ul 5 ul 5 ul 5 ul 5 ul 5 ul 5 ul 5 ul 
 
2.2.4.5. Non-denaturing Polyacrylamide Gel Analysis 
In order to resolve the protein-DNA complexes from the free DNA, %6 non-
denaturing TBE polyacrylamide gels were prepared according to the table below 
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(Table 2.14), which gives the amount of each ingredient required to make 2 gel of 
0.75 mm thickness. 
 
Table 2.14 : The volume of  TBE Polyacrylamide Gels Components 
Component Volume 
Acrylamide:bisacrylamide (29:1) (30%, w/v)                   
H2O   
5x TBE buffer 
Ammonium Persulfate (APS) (10%, w/v) 
TEMED 
2.4 ml 
7.2 ml 
2.4 ml 
200 ul 
20 ul 
Total volume 12 ml 
 
Non-denaturing gel solution was poured into the gel casting forms and alllowed for 2 
hours at room temperature for complete polymerization. Then, gels were pre-run at 
60 volt for 30 min so as to remove the all the traces of ammonium persulfate and to 
provide an ion equilibration between the gels and running buffer. After loading all 
the AbrB and Spo0A binding reaction samples into the wells, gels were run in 
electrophoresis buffer (50 mM KCI, 5 mM MgCI2, 0.1 mM EDTA) at 80 volts for 3 
hours. After that, polyacrylamide gels were stained in TBE buffer (Appendix B) 
containing  1:10.000 diluted SYBR Green dye for 30 min with a gentle shaking in 
the dark. Gels stained with SYBR Green stain were visualized using the UV 
transilluminator source. 
 
2.2.5. DNase I Footprinting of AbrB and Spo0A Proteins 
2.2.5.1. Synthesis and Purification of FAM-Labelled Probe 
pJET-yvfIprom plasmid, which contain the yvfI promoter, was used in PCR reaction 
as a template in order to prepare 414 bp single end 5'-FAM-labelled probe. The 
oligonucleotide primers yvfI P/ F2  and  yvfI P/ R2, given below, are the forward and 
the reverse primers for the amplification of the FAM-labelled DNA probe 
comprising the putative binding regions for AbrB and Spo0A proteins. 
 
yvfI P/ F2  : 5' – 5'-FAM- CTGGCGCCATATGTAAGCGGT– 3' 
yvfI P/ R2  : 5' – GCCTTCTCCCAGTTTCAT– 3' 
 
33
                            Table 2.15 : The volume of PCR components 
 
 
 
 
 
 
 
 
 
 
 
PCR components given in Table 2.15 were combined in a 0.2 ml tubes on ice. The 
final concentrations of the primers and dNTP mix were 0,5 µM and 0,2 µM 
respectively. PCR reaction was cycled 30 times according to the cycling program 
below, enabling the heated lid: 
 
PCR conditions 
 
95 °C,  2 min           1 cycle (Initial denaturation) 
95 °C,  1 min 
55 °C,  1 min           30 cycles  +  72 °C, 10 min       1 cycle  (Final extension) 
72 °C,  1 min 
 
After the amplification of the 414 bp FAM-labelled DNA probe that encompasses 
bases –396 to +18 in relation to the translational start point of the yvfI gene 
(Appendix F), probe was purified using the QIAquick PCR Purification Kit (Qiagen), 
as done in section 2.2.4.3 exactly in the same way. 
 
2.2.5.2. Binding Reactions of Protein-Probe DNA  
After the amplification and purification of the single end FAM-labelled probe, the 
following binding reactions were set up according to the Table 2.16 for the DNase I 
footprinting of AbrB and brought to 35 ul with the dH2O. AbrB reaction tubes (1-4) 
included varying amounts of AbrB protein ranging from 0 to 45 ug were incubated at 
Component  Exp.      (-) Control 
ddH2O 40,5 µl 42,5 µl 
10X pfu Buffer 5 µl 5 µl 
dNTP 1 µl 1 µl 
F Primer 0,5 µl 0,5 µl 
R Primer 0,5 µl 0,5 µl 
Template  2 µl - 
pfu DNA polymerase 0,5 µl 0,5 µl 
Total  50 µl 50 µl 
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room temperature for 25 min in binding buffer B (50 mM KCI, 5 mM MgCI2,, 0.1 
mM EDTA, 1 mM DTT and % 8  glycerol, pH:8.0). Reaction tube 1 including the 
BSA protein instead of the AbrB protein was the control tube of the footprinting 
assay. 
 
Table 2.16 : Binding Reactions for DNase I Footprinting of AbrB Protein 
 1 2 3 4 
DNA fragments 1 ug 1 ug 1 ug 1 ug 
Poly      (dI-dC) 2 ug 2 ug 2 ug 2 ug 
AbrB protein - 15 ug 30 ug 45 ug 
BSA 20 ug - - - 
5X binding buffer B 7 ul 7 ul 7 ul 7 ul 
 
For the Spo0A footprinting assay, all the ingredients shown in Table 2.17 were 
mixed in 0.2 ml reaction tubes and brought to 35 ul with the dH2O. Reaction tubes 
(1-4)  containing different amounts of Spo0 protein ranging from 0 to 60 ug were 
incubated at room temperature for 25 min in binding buffer A (20 mM Hepes, 1 mM 
EDTA, 10 mM (NH)4SO4, 1 mM DTT, %0,2 Tween 20 and 30 mM KCI, pH:8.0). 
BSA protein was used instead of AbrB protein in reaction tube 1 (Control tube). 
 
Table 2.17 : Binding Reactions for DNase I Footprinting of Spo0A Protein 
 1 2 3 4 
DNA fragments 1 ug 1 ug 1 ug 1 ug 
Poly      (dI-dC) 2 ug 2 ug 2 ug 2 ug 
Spo0A protein - 20 ug 40 ug 60 ug 
BSA 16 ug - - - 
5X binding buffer A 7 ul 7 ul 7 ul 7 ul 
 
2.2.5.3. DNase Treatment  
After binding reaction of protein-probe DNA, 0.00816 Knutz Unit of DNase I 
(Roche) is added to reaction tubes and incubation proceeded for 3 min at room 
temperature. DNase I was inhibited by incubating the reaction tubes at 75°C for 10 
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min. Then, resulted DNA fragments were purified with the QIAquick PCR 
Purification kit and eluted with 30 µl dd H2O, previously as done in section 2.2.4.3. 
10 µl of digested DNA was added to 9.9 µl Hi-Di formamide and   0.1 µl 500 LIZ 
size standart. 
 
2.2.5.4. DNA Fragment Analysis  
All samples were analyzed with the 3130 DNA Sequence Analyzer (Applied 
Biosystems) running a default Genemapper 50-POP7-1 module with the 3 kV 
injection voltage and 30 seconds injection time. After running the samples, 
electropherograms obtained from the DNA sequence analyzer (Applied Biosystems) 
were aligned with Peak Scanner Software v1.0 (Applied Biosystems). 
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3. RESULTS AND DISCUSSION 
3.1. Construction of pJET-abrB and pJET-spo0A Cloning Vectors 
 
The insert preparation that would be  cloned into cloning vectors had been achieved 
by the means of polymerase chain reaction using the chromosomal DNA of B. 
subtilis PY79 wild type strain as template DNA. The primers 5'– CGGCCATGGGT 
ATGTTTATGAAATCTACTGGT – 3' and 5' – GCCGGATCCTTTAAGGTTTTGA 
AGCTG – 3' were the forward and reverse primers that had been used for the 
amplification of 288 bp abrB gene. For the  amplification of  375 bp spo0A gene,  5'–
CGGCCATGGGTGAGAAAATTAAAGTTTGT– 3' and 5'– GCCGGATCCAG 
AAGCCTTATGCTCTAACCT – 3' forward and reverse primers were used in PCR 
reaction. Underlined sequences are the recognition sites for BamHI and NcoI 
restriction enzymes on forward and reverse primers respectively. After PCR, the 
amplified fragments including the abrB and spo0A genes were seperated on %1 
agarose gel electrophoresis and visualized by UV trans-illuminator.  
 
 
 
 
 
 
 
 
 
 
Fig. 3.1: Amplification  of abrB  gene by PCR. Marker 10 : PhiX174 DNA / BsuRI 
(lane 1), amplified abrB gene fragment (lane 2), control pcr (lane3) 
 
Agarose gel images of abrB and spo0A PCRs have demonstrated the amplifications 
of the 375 bp spo0A and 288 bp abrB genes (Fig. 3.1 and Fig 3.2). 
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Fig. 3.2: Amplification  of spo0A gene by PCR. Marker10 : PhiX174 DNA / BsuRI 
     (lane 1), amplified spo0A gene fragment (lane 2), control pcr (lane3) 
 
Amplified DNA fragments including abrB and spo0A genes were ligated into the 
pJET cloning vectors (Fermentas) and the newly contructed vectors,  pJET-abrB and 
pJET-spo0A, were transformed to electrocompotent E.coli Top 10F' cells via  
Eppendorf Electroporator 2510.  
Having done the transformation of the new generated plasmids, pJET-abrB and 
pJET-spo0A, to the E.coli cells, plasmids were amplified in E.coli cells and they 
were harvested through plasmid isolation protocol, and visualized on agarose gel as 
shown in Fig. 3.3 and Fig. 3.4.  
 
 
 
 
 
 
 
 
 
Fig. 3.3: Plasmid DNAs containing abrB gene isolated from E.coli Top10 AmpR 
            transformants (lane 1-6). Marker 3: Lambda DNA / EcoRI + HindIII 
                   (lane 7). 
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Fig. 3.4: Plasmid DNAs containing spo0A gene isolated from E.coli Top10 AmpR 
                  transformants (lane 1-6). Marker 3: Lambda DNA / EcoRI + Hind III    
                  (lane 7). 
 
Plasmids having different conformations and concentrations were selected and 
digested with BamHI and NcoI restriction enzymes so as to confirm whether abrB 
and spo0A genes had been cloned into cloning vector or not. Convenient plasmids 
including the abrB and spo0A genes (pJET-abrB and pJET-spo0A) were selected as 
subcloning sources for ligation into pQE60 vector. 
 
3.2. Construction of pQE60-abrB and pQE60-spo0A Expression Vectors  
 
Plasmids including abrB and sp0A genes (pJET-abrB and pJET-spo0A) were 
selected for ligation of the abrB and spo0A genes into the pQE60 vector. In this 
purpose, 3431 bp pQE60 expression vector and and selected plasmids were digested 
with the same enzymes, BamHI and NcoI,  in order to create sticky ends that could 
be hybridized with each other. Agarose gel images of the double digestions were 
shown in Fig. 3.5 and Fig.3.6. 
 
 
Fig. 3.5: Double digestions of pJET vector including abrB (lane 2) and spo0A genes   
                with BamHI and NcoI (lane3).  Marker 10 : PhiX174 DNA /BsuRI (lane 1). 
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Fig. 3.6: Double digestions of pQE60 vectors with BamHI and NcoI (lane1-2). 
                    Marker 10 : PhiX174 DNA /BsuRI (lane 3). 
 
After that, linearized form of pQE60 vector and digested abrB and spo0A fragments 
from pJET-abrB and pJET-spo0A were exracted from agarose gel. DNA fragments 
including abrB and spo0A genes were ligated into linearized pQE60 with T4 DNA 
ligase by incubation at 16°C for overnight to create the pQE60-abrB and pQE60-
spo0A plasmids. Following that, transformations of pQE60-abrB and pQE60-spo0A 
plasmids into the E.coli competent cells via  Eppendorf Electroporator 2510 were 
performed. After 16 hours inoculaton of the cells on LB agar plate containing amp 
(100µg/ml), the resulting 50 transformants were picked up and used for plasmid 
DNA isolation to verify the cloning of abrB and spo0A genes fragments. Insertions 
of the abrB and spo0A genes into the pQE60 expression vectors were confirmed by 
double digestion of the newly constructed plasmids, pQE60-abrB and pQE60-spo0A, 
with BamHI and NcoI restriction enzymes. Figure 3.7 and Figure 3.8 indicated the 
insertions of the abrB and spo0A genes into the pQE60 expression vectors. 
 
 
Fig. 3.7: The double digestion of a selected plasmid including abrB gene isolated 
        from E.coli AmpR transformants (lane2). Marker 3: Lambda DNA / 
                  EcoRI + HindIII (lane 1). 
 
41
 
Fig. 3.8: The double digestion of a selected plasmid including spo0A gene isolated 
                 from E.coli AmpR transformants (lane2). Marker 3: Lambda DNA / EcoRI       
                 + HindIII (lane 1). 
 
Selected pQE60-abrB and pQE60-spo0A plasmids were sequenced by using  PRISM 
Ready Reaction Dye-Deoxy terminator cycle sequencing kit (Applied Biosystems) 
and sequence results were analyzed on the ABI PRISM 3100 DNA sequencer. 
Obtained sequence data sets for abrB and spo0A genes were compared to the B. 
subtilis 168 genome sequence at National Center for Biotechnology Information 
(NCBI) database using the BLAST search. 
 
3.3. Expression and Purification of 6xHis-tagged Spo0A and AbrB Proteins 
After the transformation of pQE60-abrB and pQE60–spo0A plasmids to the E.coli 
cells, colonies harboring the convenient pQE60-abrB and pQE60-spo0A plasmids 
were selected according to the results of BLAST searches. After that, desired 
colonies were grown in LB medium and were induced with IPTG for overexpression 
of interested AbrB and Spo0A proteins. Overexpressied proteins were purified using 
Ni-NTA resin molecules. To evaluate the expression level of the desired proteins and 
purification quality of each step, all fractions collected during protein purification  
were analyzed by SDS-PAGE staining with Coomassie brilliant blue (Fig. 3.9 and 
Fig. 3.10).  
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Fig. 3.9: Purified AbrB protein. Protein Molecular Weight Marker (M), total 
           homogenate from uninduced cell (lane 1), total homogenate from  
          induced cell (lane 2), total supernatant fraction from induced cell  
                      (lane 3), subsequent washes of supernatant fraction  (lane 4-6),   
                      subsequent elutes from supernatant fraction (lane 7-9). 
 
 
While lane 1 in Figure 3.9 belongs to the total homogenate of uninduced colony, lane 
2 and lane 3 represent the total homogenate and total supernatant fractions that were 
obtained from the induced abrB colony, respectively. When compared to the induced 
and uninduced total homogenate fractions (lane 1 and lane 2), a notable thick band, 
near the bottom of the SDS-PAGE, corresponding to a protein of approximately 11 
kDa implies the successful AbrB induction. The wash fractions (lane 4-6) and elution 
fractions (lane 7-9) indicate that unwanted proteins had been removed efficiently and 
most of the target AbrB protein retained and purifed. In elution fractions (lane 7-9), 
there is also a thick band corrosponding to the protein of about 25 kDa suggesting the 
existence of dimeric form AbrB protein (Fig. 3.9).  
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Fig. 3.10: Purified Spo0A protein. Total homogenate from uninduced cell (lane 1),   
             protein molecular weight marker (M), total homogenate from induced    
                   cell (lane 2), total supernatant fraction from induced cell (lane 3),   
                   subsequent washes of supernatant fraction  (lane 4-6), subsequent elutes   
                   from supernatant fraction (lane 7-9) 
 
 
When it comes to Spo0A protein, lane 1 and lane 2 in figure 3.10 represent total 
homogenates from uninduced and induced colonies, respectively. A notable thick 
band whose size is  approximately 13 kDa at the bottom of the SDS-PAGE indicates 
the induction of the Spo0A protein. Subsequent washes of the supernatant fraction 
(lane 4-6) removed most of the unwanted proteins and a remarkable amount of the 
desired Spo0A protein (lane 7-9) was purified efficiently (Fig. 3.10). 
 
3.4. Electromobility Shift Assays of AbrB and Spo0A Proteins 
 
The possible binding sites for AbrB and Spo0A regulator proteins on yvfI promoter 
were studied by electromobility shift assay. EMSA was performed using non-specific 
double stranded oligonucleotides (Poly [dI-dC]). The binding of purified AbrB and 
Spo0A  proteins to the double stranded oligonucleotides is presented in Fig. 3.11 and 
Fig. 3.12. Clear shifts were produced for both of the AbrB and Spo0A proteins. 
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Fig. 3.11 :  Non-denaturing polyacrylamide gel image of electromobility shift assay    
                 (EMSA) of purified AbrB with yvfI promoter of B. subtilis. Free DNA     
            (yvfI promoter DNA, lane 1), yvfI promoter DNA with BSA protein   
               (lane 2), increasing amounts of AbrB protein from 6 ug to 42 ug with   
     yvfI promoter (lane 3-9). Specific DNA/protein interactions are  
                     indicated at the level of two arrows. 
 
Fig. 3.11 shows the effect of increasing amounts of AbrB protein on the 
electromobility of B. Subtilis yvfI promoter DNA. In lane 1 containing B. Subtilis yvfI 
promoter DNA alone, a single band was observed. The same band was observed for 
the samples containing B. Subtilis yvfI promoter DNA and AbrB protein (lane 3- 9) ; 
but the intensity of the band was lower when the amount of the AbrB protein 
increased. On the other hand, existence of the BSA protein instead of AbrB protein 
(lane 2) did not produce any shift, thereby indicating the specifity of DNA-protein 
complex. 
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Fig. 3.12 : Non-denaturing polyacrylamide gel image of electromobility shift assay 
                 (EMSA) of purified Spo0A with yvfI promoter of B. subtilis. Free DNA   
           (yvfI promoter DNA, lane 1), yvfI promoter DNA with BSA protein   
                    (lane 2), increasing amounts of AbrB protein from 10 ug to 60 ug with           
                    yvfI promoter (lane 3-8). Specific DNA/protein interactions  are   
                    indicated at the level of two arrow. 
 
 
In electromobility shift of Spo0A protein, mobility of the yvfI promoter DNA was 
not retarded and migrated to the bottom of the gel faster in the absence of the Spo0A 
protein (Fig. 3.12, lane 1), even in the presence of the non-specific competitor 
protein, BSA (Fig. 3.12, lane 2). However, when the yvfI promoter DNA was 
incubated with the Spo0A protein, mobility of the DNA was retarded because of the 
DNA-protein complex formation (Fig. 3.12, lane 3-8). Besides, intensities of the 
bands were reduced due to the increasing amount of the Spo0A protein in the 
samples (lane 3-8). 
These results suggest that transcriptional regulators,  AbrB and Spo0A proteins, bind 
to yvfI promoter and are involved in the transcriptional regulation of the yvfI gene 
expression. 
 
3.5. DNase I Footprinting of AbrB and Spo0A Proteins 
 
After revealing that both of the transcriptional regulator proteins, AbrB and Spo0A,  
bind to the yvfI promoter, DNase I footprinting assay was employed to verify the 
exact binding sites of the regulator proteins. For this aim, 414 bp single end 5'-FAM-
labelled probe (-396 to +18 relative to the translational start point of the yvfI gene, 
Appendix F) was synthesized and incubated with the increasing amount of the 
interested protein. After the DNase I digestion, samples were run on 3130 DNA 
Sequence Analyzer and aligned with Peak Scanner Software v1.0 for protection 
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pattern. As negative control reaction, BSA protein was used instead of the AbrB and 
Spo0A proteins. As expected, the digested DNA patterns were very similar when 
comparing desired proteins to BSA-involved control fragments. In other words, BSA 
involvement did not produce any protected region.  
 
In Figure 3.13, blue electropherograms represent the protected sample, while the red 
ones represent the unprotected sample in AbrB footprinting.  After superimposing 
the red (in absence of the AbrB protein) and blue (in presence of AbrB protein) 
electropherograms for the visual analysis of the protected regions, the protected 
region for AbrB was determined to be 12 bases in length, from -316 to -304 relative 
to the translational start point of the yvfI gene (Appendix F) as seen in Fig. 3.13. The 
protected region is indicated by the horizontal bracket. 
 
 
Fig. 3.13: Electropherograms shows the protection pattern of the yvfI promoter in the   
              presence (blue) or absence (red) of AbrB. From top to bottom, increasing   
               amount of the AbrB protein protects the DNA being cleaved by DNase I. 
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Moreover, increasing amount of the AbrB protein (from top to bottom) protects the 
binding location more efficiently as seen in Fig. 3.13.  
 
 
Fig. 3.14: Electropherograms shows the protection pattern of the yvfI promoter in the 
            presence (blue) or absence (red) of Spo0A protein. From top to bottom,   
               increasing amount of the Spo0A protein protects the DNA being cleaved   
                  by DNase I. 
 
In Figure 3.14, the blue electropherograms represent the Spo0A involved samples, 
whereas the red electropherograms are from the BSA control. After superimposing 
the protected (blue electropherograms) and unprotected (red electropherograms) 
samples, the binding region of the Spo0A, thereby the protected region, was 
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corresponded to the bases -7 to +1 in relation to the translational start point of the 
yvfI gene (Appendix F). The protected region is indicated by the horizontal bracket. 
Also, the increasing amount of the Spo0A protein (from top to bottom) make the 
protected region being cleaved by the DNase I, more efficiently (Fig. 3.14). 
 
The proteced regions for AbrB and Spo0A proteins on yvfI promoter are compatible 
with the putative binding sites exactly the same size and same location that were 
determined previously (Sierro et al, 2008).   
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4. CONCLUSION  
It is known that AbrB and Spo0A regulator proteins to be responsible in antibiotic 
synthesis. There are so many genes and operons that are regulated by Spo0A and 
AbrB. TasA operon (Stover and Driks, 1999) and subtilosin operon  (Zheng et al, 
1999) are a few examples whose regulations are subject to AbrB and Spo0A 
proteins. Dipeptide antibiotic bacilysin is also under the regulatiom of AbrB and 
Spo0A proteins. B. subtilis whose spo0A gene is mutated can not produce bacilysin 
efficiently compared to the wild type ones. On the other hand, mutation in the abrB 
makes the B. subtilis produce more bacilysin indicating its negative control on 
bacilysin (Zuber et al, 1987; Yazgan et al., 2003). Recently, the necessity of the yvfI 
gene in bacilysin biosynthesis has been proved (Köroğlu et al, 2008).  
Besides, yvfI gene promoter contains potential binding sites for AbrB and Spo0A 
transcriptional regulators. In order to determine whether AbrB and Spo0A proteins 
bind to the mentioned region, firstly FAM-labelled oligonucleotide encompassing the 
candidate binding sites, -396 to +18 in relation to the translational start point of the 
yvfI gene (Appendix F), was synthesized. Candidate proteins were subjected to the 
EMSA for their abilities to bind the target probe. Results obtained from the 
electromobility of AbrB and Spo0A revealed the shift in yvfI promoter, thereby 
binding abilities of the  mentioned proteins to the yvfI promoter. Subsequent capillary 
electrophoresis based DNase I footprinting experiments demonstrated that AbrB 
binds to a region covering the sequence from -316 to -304 and Spo0A to -7 to +1 
relative to the translational start point of the yvfI gene. The found binding regions of 
AbrB and Spo0A on yvfI promoter are well matched to putative DNA sequences 
previously shown (Sierro et al., 2008).  
 
Based on these results, it can be said that transcription of the yvfI gene underlies a 
regulation exerted by the global regulator proteins, AbrB and Spo0A. When taken 
the recent findings into consideration (Yazgan et al., 2003), it is figured out that 
global transient-phase regulator protein, AbrB, is  a repressor of the bacilysin by 
 
50
hindering the yvfI expression, while the Spo0A is a transcritional factor acting as 
activator on yvfI expression so that on bacilysin production in B. subtilis. 
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APPENDIX A 
Compositions and Preparation of Culture Media 
 
Luria Bertani (LB) Medium (1000ml) 
Tryptone                   10 g/L 
Yeast Extract  5 g/L 
NaCl   5 g/L 
Distilled H2O was added up to 1000 ml and then autoclaved for 15 min. 
 
Luria Bertani (LB) Agar Medium (1000 ml) 
Tryptone  10 g/L 
Yeast Extract    5 g/L 
NaCl2     5 g/L 
Agar   15 g/L 
Distilled H2O was added up to 1000 ml and then autoclaved for 15 min. 
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APPENDIX B 
Compositions of Buffers and Solutions 
 
Gel Stain  
Methanol 50 ml 
Glacial acetic acid                                                10 ml 
H2O                                                                       50 ml 
Coomassie Brilliant Blue R 0.275 g 
 
 
Destaining Solution  
Methanol 75 ml 
Glacial acetic acid                                                50 ml 
H2O                                                                       875 ml 
 
 
50X TAE Buffer (Tris-Acetate-EDTA) 
Tris base                               242 gm                                                                                                                      
Acetic Acid                          57.1 mL                                                                                                          
0.5 M EDTA                        100  mL (shake vigorously before use) 
Add ddH2O to 1 Liter and adjust pH to 8.5 using KOH.  
 
 
TBE Buffer  (Tris-Boric acid-EDTA) 
Tris base                                 108g 
 Boric acid                              55g 
0.5M  EDTA                          40ml,  (pH 8.0) 
  
Add ddH2O to 1 Liter.  
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Lysis Buffer  
50 mM NaH2PO4  
300 mM NaCl  
10 mM imidazole  
 
Adjust pH to 8.0 using NaOH. 
 
 
Wash Buffer  
50 mM NaH2PO4  
300 mM NaCl  
20 mM imidazole  
 
Adjust pH to 8.0 using NaOH. 
 
 
Elution Buffer  
50 mM NaH2PO4  
300 mM NaCl  
250 mM imidazole  
Adjust pH to 8.0 using NaOH. 
 
 
3X SDS Loading Dye 
200 mM  Tris-HCl (pH 6.8)                                                                                                  
100 mM  NaCl                                                                                                                     
100 mM  DTT                                                                                                                          
3 mM      EDTA                                                                                                           
30%        Glycerol                                                                                                                             
6%          SDS                                                                                                                           
0.02%     Bromophenol blue 
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APPENDIX C 
Enzymes and Chemicals 
Enzyme 
 
Supplier 
Lysozyme                                                                       Sigma 
 
Chemical  
 
Supplier 
Acrylamide Merck 
Agar                                                    
Alanine 
Sigma 
AppliCHEM 
Ammonium persulfate Merck 
Bis-acrylamide Merck 
Coomassie Brilliant Blue R Sigma 
Ethanol Riedel-de Haën  
Fructose Merck 
Glycial Acetic Acid Riedel-de Haën 
Glycerol Merck 
Glycine Merck 
HCl  Merck 
KH2PO4 Merck 
K2HPO4 Merck 
KOH Sigma 
Methanol                                                                              Riedel-de Haën 
Na2SO4.10H2O Merck 
Natrum hydroxid (NaOH) Riedel-de Haën 
Nutrient broth Merck 
Potassium chloride (KCl) Riedel-de Haën 
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2-propanol Riedel-de Haën 
Riboflavin Merck 
SDS Merck 
Sodium chloride (NaCl) Riedel-de Haёn 
Sodium hydrogen phosphate(Na2HPO4.7H2O) Merck 
TEMED Carlo Ederba 
Tris (hydrocymethyl) aminomethane Merck 
Tryptone Sigma 
Yeast Extract Sigma 
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APPENDIX D 
Markers………………………………………………………………Fermentas  
 
phiX174 DNA/HinfI Marker, 10                   Lambda DNA/EcoRI+HindIII Marker, 3 
 
   
         
 
 
 
 
 
                                                 
               
 
 
Unstained Protein Molecular Weight Marker 
 
 
 
 
 
 
 
 
 
 
 
66
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67
 
 
 
 
APPENDIX E 
 
      yvfI DNA Sequence 
       1 atgaaacagg gagaaggcac gtatctgaag gaatttgagc tcaatcaaat ttctcagccg 
      61 ctctcagccg cccttctgat gaaaaaagag gacgtcaagc agctgctcga ggtcagaaaa          
     121 ctgcttgaaa tcggcgtggc ttcactagcg gctgaaaaaa ggacagaagc agatctcgaa 
     181 agaattcagg atgcactaaa ggaaatgggc agcattgaag cggacgggga gctgggagag 
     241 aaagcagact ttgcatttca tcttgcgctt gcggacgctt ctcaaaatga acttcttaaa 
     301 cacttgatga atcacgtgtc atcattgctg ctggaaacaa tgagggaaac gaggaaaatc 
     361 tggctgtttt ccaagaagac ctccgttcag cggctgtatg aggagcacga acggatttac             
     421 aatgctgtgg ctgccgggaa cggtgcacag gcggaagccg ccatgctggc gcatttgacg 
     481 aatgtggaag atgtgctttc gggatatttc gaggaaaatg tgcaataa 
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APPENDIX F 
 
Mapping of the yvfI Promoter 
 
aataatcggtacaagtgcggcaagcgctgataatagcaaatttccccctataggcgtatatgcctgtgtccattgcatccca
aacccctccttgaaacataaactggcgccatatgtaagcggtttctatagatgatatgatcatctgatgactgggtaataaga 
ccagttacctagcattatattttgaaaaaaatcaaagtacaagactttttgacaaaatagtcaaaatcttttggcggccc  
                           AbrB                                  AbrB          AbrB       
acaaaacagagtataatagatcgtaaacagccagacctacaagttacggggtgaattgcattgaaatataaacagatt 
 
aaaacaaaaaaatatatgaagaagtagcggatgccctattagatatgatcaaaaatggcgaattgaagccgggggata 
                                                                                             Spo0A    
aactggactctgttcaggcgcttgctgagagctttcaagtcagccgttcagcggttcgcgaagcactttctgcgctaaa 
 
agcgatggggcttgtcgaa       Atg aaa cag gga gaa ggc acg tat ctg  
                    Spo0A         M   K   Q    G    E   G    T    Y   L 
 
 
The translational start point of the yvfI is indicated by bold uppercase letter.  
Potential cis-acting elements to which AbrB and Spo0A might bind were found by 
the help of the DBTBS database (Sierro et. al., 2008). These potential binding sites 
are indicated with names below the sequences and shown in blue and yellow 
background colors respectively.  
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APPENDIX G 
 
Laboratory Equipment  
 
Autoclave: Tuttnauer Systec Autoclave (2540 ml) 
Balances: Precisa 620C SCS 
      Precisa 125 A SCS 
Centrifuge: Beckman Coulter, Microfuge 18  
Centrifuge rotor: F241.5P 
Deep freezes and refrigerators: -80°C Heto Ultrafreeze 4410 
           -20°C Arçelik 209lt 
            +4°C Arçelik 
Electrophoresis equipments: E – C mini cell primo EC320 
Gel documentation system: UVI PHotoMW Version 99.05 for Windows 
Incubators: Nüve EN400 
          Nüve EN500 
Orbital shaker incubators: Sertomat S – 2 
              Thermo 430 
Pipettes: Gilson pipetteman 10 µl, 20 µl, 200 µl, 1000 µl 
      Volumate Mettler Toledo 10 µl, 20 µl, 200 µl, 1000 µl 
      Eppendorf research 10 µl, 20 µl, 200 µl, 1000 µl 
pH meter: Mettler Toledo MP220 
Spectrophotometer: PerkinElmer Lambda25 UV/VIS Spectrometer 
Thermomixer: Eppendorf thermomixer comfort (1.5 ml) 
Transillumunator: Biorad UV transilluminator 2000 
Vortexing machine: Heidolph Raax top  
Waterbaths: Memmert wb-22 
Ultrafiltration tube: VIVASPIN 
Lyophilizator : ALPHA 1-2 LD plus 
Power supply: Bio-Rad 
Dialysis Tubing Cellulose Membrane: Sigma-Aldrich 
SDS-PAGE Apparatus: Bio-Rad 
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Polyacrylamide Gel Electrophoresis Apparatus: Bio-Rad 
GS-800 CALIBRATED DENSITOMETER: Bio-Rad 
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